CSBR Earnings
Latest Revenue13.8M
Latest Net Income-667000
| Period | EPS | Revenue | Net Income | Rev YoY | EPS YoY |
|---|
| Q4 2026 | -$0.05 | 13.8M | -667000 | +12.0% | +61.5% |
| Q3 2026 | -$0.02 | 16.6M | -279000 | -2.8% | -106.1% |
| Q2 2026 | $0.02 | 15.0M | 237.0K | +11.5% | -60.0% |
| Q1 2026 | -$0.03 | 14.0M | -466000 | -0.5% | -130.0% |
| Q4 2025 | -$0.13 | 12.4M | -1835000 | -11.8% | -1,200.0% |
| Q3 2025 | $0.33 | 17.0M | 4.5M | +41.8% | +273.7% |
| Q2 2025 | $0.05 | 13.5M | 728.0K | +16.6% | +133.3% |
| Q1 2025 | $0.10 | 14.1M | 1.3M | +11.9% | +152.6% |
| Q4 2024 | -$0.01 | 14.0M | -109000 | — | — |
| Q3 2024 | -$0.19 | 12.0M | -2530000 | — | — |
| Q2 2024 | -$0.15 | 11.6M | -2071000 | — | — |
| Q1 2024 | -$0.19 | 12.6M | -2566000 | — | — |
Champions Oncology (CSBR) — Earnings